Alnylam Announces Proposed Public Offering Of Common Stock Post author:Sam Post published:May 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why This Bay Area Biotech Could be a Cash Cow for Investors September 10, 2017 BC Platforms Closes USD $10 Million Series B Financing Led By Debiopharm And To Accelerate Knowledge Platform Development May 8, 2017 Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017
BC Platforms Closes USD $10 Million Series B Financing Led By Debiopharm And To Accelerate Knowledge Platform Development May 8, 2017
Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017